Zimbabwe has declined a substantial US healthcare agreement valued at $367m (272 million pounds) spanning five years due to the United States' demand for sensitive data.
This rejection was revealed after a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative has since stated that the United States was requesting genetic material for research and commercial purposes but was unwilling to guarantee the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged continued dialogue to find a deal agreeable to all parties so the country's vital HIV programme can continue.
Wider Background
This rejection follows a comparable situation in neighbouring Kenya, where a high court halted a similar health funding agreement following legal challenges were filed about the security of citizens' health data.
After returning to office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and accountability.
Based on statements, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.
"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our population should a new disease outbreak arise."
Sovereignty and International Frameworks
He also noted that the American exit from the global health body and its push of bilateral health agreements were undermining systems previously established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns over the US deal "are not meant as hostility towards the US," he added.
"We welcome further dialogue with our US partners on how subsequent co-operation might be structured in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
A leading public health body stated it recognised the official position, but urged that negotiations must proceed considering a large portion of the country's HIV programmes depended on foreign aid.
"In cases where technical issues exist, such as those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.
The situation underscores the ongoing debate between receiving vital international aid and safeguarding a country's data in an ever more data-driven world.